PET/MR scan

DIAGNOSTIC_TEST7 trials

Sponsors

University of Edinburgh, Tel-Aviv Sourasky Medical Center

Conditions

Cardiovascular DiseaseCervical CancerCoronary Artery DiseaseEsophageal CancerFollicular LymphomaHepatobiliary CancerLymphomaMRI

Unknown Phase

Validation of PET-MRI for Cardiovascular Disease

CompletedNCT02988531

University of EdinburghCardiovascular Disease, Coronary Artery Disease, Magnetic Resonance Imaging +3

Start: 2017-02-09End: 2017-12-07Updated: 2024-05-21

Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor

Tel-Aviv Sourasky Medical CenterNeuroendocrine Tumors

Start: 2020-03-10End: 2022-03-10Target: 50Updated: 2019-11-06

Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer

Tel-Aviv Sourasky Medical CenterProstate Cancer

Start: 2020-04-10End: 2022-04-10Target: 50Updated: 2019-11-06

Applying PET/MR in Rectal Cancer.

Tel-Aviv Sourasky Medical CenterRectal Cancer

Start: 2019-11-23End: 2021-12-23Target: 20Updated: 2019-11-06

Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI

Tel-Aviv Sourasky Medical CenterFollicular Lymphoma, Lymphoma, Non Hodgkin Lymphoma

Start: 2019-12-10End: 2021-12-10Target: 100Updated: 2019-11-06

Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities

Tel-Aviv Sourasky Medical CenterNeuroendocrine Tumors

Start: 2020-02-25End: 2022-02-25Target: 50Updated: 2019-11-06

Applying PET/MR in Oncology - a Prospective Project

Tel-Aviv Sourasky Medical CenterCervical Cancer, Esophageal Cancer, Hepatobiliary Cancer +5

Start: 2019-11-28End: 2021-11-28Target: 500Updated: 2019-11-08